MarketingRx roundup: Pfizer bows Season 2 of ‘Science Will Win’ podcast; Gilead’s Kite sponsors cancer light up nights
Cancer, specifically breast cancer, is the topic for Pfizer’s second season of its “Science Will Win” podcast debuting this week. Researchers, doctors and patients themselves will talk about the science, new innovations in targeted immunotherapies, clinical trials and the physiological and personal challenges of the disease.
The two-episode season begins on Thursday hosted by geneticist and University College London lecturer Adam Rutherford, who also hosted the first season of “Science Will Win” about gene therapy and the next generation of medicines.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,400+ biopharma pros reading Endpoints daily — and it's free.